Ancora Advisors LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$50,000
-5.7%
1,5000.0%0.00%
+100.0%
Q2 2022$53,000
-23.2%
1,5000.0%0.00%
-50.0%
Q1 2022$69,000
-30.3%
1,5000.0%0.00%0.0%
Q4 2021$99,000
+5.3%
1,5000.0%0.00%0.0%
Q3 2021$94,000
-24.2%
1,5000.0%0.00%
-33.3%
Q2 2021$124,000
+25.3%
1,5000.0%0.00%0.0%
Q1 2021$99,000
-13.9%
1,5000.0%0.00%
-25.0%
Q4 2020$115,000
+76.9%
1,5000.0%0.00%
+33.3%
Q3 2020$65,0000.0%1,5000.0%0.00%0.0%
Q2 2020$65,000
+51.2%
1,5000.0%0.00%
+50.0%
Q1 2020$43,0001,5000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$20,836,12814.83%
Aquilo Capital Management, LLC 1,018,474$25,869,24010.72%
Rokos Capital Management LLP 1,675,921$41,537,7023.07%
COMMODORE CAPITAL LP 575,000$14,605,0002.22%
Privium Fund Management B.V. 259,036$6,579,5142.21%
JOHNSON & JOHNSON 247,598$6,288,9892.05%
WEALTH EFFECTS LLC 156,810$3,982,9762.04%
M28 Capital Management LP 67,400$1,711,9601.94%
Evolutionary Tree Capital Management, LLC 51,878$1,317,7011.83%
Avidity Partners Management LP 1,741,300$44,229,0201.47%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders